Published in PLoS One on March 31, 2015
Phytochemicals Approach for Developing Cancer Immunotherapeutics. Front Pharmacol (2017) 0.76
Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels. PLoS One (2017) 0.75
Optimization of the fermentation process of Cordyceps sobolifera Se-CEPS and its anti-tumor activity in vivo. J Biol Eng (2016) 0.75
Dendritic cell vaccines: A review of recent developments and their potential pediatric application. Hum Vaccin Immunother (2016) 0.75
Animal lectins: potential receptors for ginseng polysaccharides. J Ginseng Res (2015) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (1998) 12.70
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (1998) 12.07
CD28/B7 system of T cell costimulation. Annu Rev Immunol (1996) 10.48
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol (1997) 5.48
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature (2006) 5.19
Preparing for the next pandemic. N Engl J Med (2005) 4.65
CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev (2006) 4.49
Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer (2004) 4.43
Dendritic cell immunotherapy: mapping the way. Nat Med (2004) 4.28
Myeloid C-type lectins in innate immunity. Nat Immunol (2006) 3.41
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med (1982) 3.34
CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med (1999) 2.77
Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J Exp Med (1998) 2.72
Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol (2014) 2.71
Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med (2004) 2.68
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 2.63
Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest (2002) 2.55
A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature (1997) 2.44
A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol (2003) 2.42
TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep (2012) 2.20
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity. J Immunol (2000) 2.06
A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun (2004) 1.99
Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J Exp Med (2002) 1.91
The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol (2009) 1.88
Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood (2004) 1.84
Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A (2007) 1.75
Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control. Cancer Res (2011) 1.64
The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun (2003) 1.64
Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. Cancer Res (2009) 1.49
Adjuvants for cancer vaccines. Semin Immunol (2010) 1.48
Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol (2007) 1.36
Does surgery modify growth kinetics of breast cancer micrometastases? Br J Cancer (2001) 1.31
MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. J Leukoc Biol (2005) 1.22
Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutr J (2010) 1.20
Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy. J Immunother (2008) 1.16
In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett (2007) 1.16
Structural features and biological activities of the polysaccharides from Astragalus membranaceus. Int J Biol Macromol (2013) 1.15
The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg (2009) 1.15
Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors. J Immunol (2012) 1.14
Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. J Invest Dermatol (2008) 1.13
Dendritic cells in cancer immunotherapy. Adv Cancer Res (2008) 1.12
Systemic use of tumor necrosis factor alpha as an anticancer agent. Oncotarget (2011) 1.08
Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. J Immunol (2011) 1.08
Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice. J Ethnopharmacol (2011) 1.06
C-type lectin-like receptors on myeloid cells. Ann Med (2006) 1.05
Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28. Blood (2011) 1.04
CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity. Semin Immunol (1998) 1.04
Protective effect of ginseng polysaccharides on influenza viral infection. PLoS One (2012) 1.03
Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol (2013) 1.02
Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification. Endocr Metab Immune Disord Drug Targets (2009) 1.01
IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production. J Immunol (2011) 0.99
Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol (2012) 0.97
Role of adjuvants in modeling the immune response. Curr Opin HIV AIDS (2010) 0.96
Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer. J Clin Oncol (2007) 0.96
Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Cancer Immunol Immunother (2012) 0.96
Mushroom immunomodulators: unique molecules with unlimited applications. Trends Biotechnol (2013) 0.95
Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients. J Transl Med (2006) 0.93
Dendritic cell-based vaccines: barriers and opportunities. Future Oncol (2012) 0.91
Shenqi fuzheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review. J Exp Clin Cancer Res (2010) 0.90
Clinical utilization of chemokines to combat cancer: the double-edged sword. Expert Rev Vaccines (2007) 0.89
Retracted An effective vaccine strategy protective against antigenically distinct tumor variants. Cancer Res (2008) 0.88
Structural and immunological studies of a pectin and a pectic arabinogalactan from Vernonia kotschyana Sch. Bip. ex Walp. (Asteraceae). Carbohydr Res (2005) 0.87
The contribution of side chains to antitumor activity of a polysaccharide from Codonopsis pilosula. Int J Biol Macromol (2012) 0.85
Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy. Int J Radiat Biol (2012) 0.85
Specific Dioscorea Phytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines. Evid Based Complement Alternat Med (2013) 0.84
Codonopsis pilosula polysaccharide attenuates cecal ligation and puncture sepsis via circuiting regulatory T cells in mice. Shock (2014) 0.80
Interleukin-4 enhances trafficking and functional activities of GM-CSF-stimulated mouse myeloid-derived dendritic cells at late differentiation stage. Exp Cell Res (2011) 0.80
CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors. Mol Cancer (2014) 0.79